Immediate Relief of Post-Stroke Shoulder Pain, January 2018
Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Request a Consultation
Complete the Request a Consultation Form or call
+1 (561) 353-9707 to request a phone or in-office consultation with an INR medical provider.
Edward Tobinick, M.D., the founder and Director of the Institute of Neurological Recovery, invented the remarkable breakthrough perispinal etanercept treatment for stroke and chronic brain injury, first used in 2010, now, in 2022, with thousands of patients treated from 91 countries.
In October 2018, the Australian Government announced their designation of substantial funding to study perispinal etanercept(PSE) for treatment of stroke. On January 3, 2020 a university, double-blind, randomized, placebo-controlled, clinical trial confirmed the efficacy of perispinal etanercept for treatment of chronic, post-stroke pain. Dr. Tobinick was instrumental in the design of the university study.
The INR accepts patients for treatment from all parts of the world, and has treated patients from every populated continent of the world.
Scientific articles from hundreds of academic scientists around the world have cited INR publications.
